4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-021611
Chief Commercial Officer sold 2,050 shares at $84.65 ($173,533)
- Chief Commercial Officer acquired 2,050 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hoerter Steven L. Chief Commercial Officer | 2018-03-22 | Option exercise | +2,050 | $39.76 | $81,508 | 2,050 | D: show line 1 in the form |
| Hoerter Steven L. Chief Commercial Officer | 2018-03-22 | Sale | −2,050 | $84.65 | $173,533 | 0 | D: show line 2 in the form |
| Open-market sales · 2,050 sh · avg $84.65 · $173,533 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Hoerter Steven L. Chief Commercial Officer | 2018-03-22 | Option exercise · Stock option (right to buy) | −2,050 | 70,900 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…